Scout scanned 101 NASDAQ 100 constituents and short-listed 25 candidates for deep analysis by the five analysts. Here is what happened to each one.
- ADPAutomatic Data Processing, Inc.Dropped at merge
Scout: Only 1.2% below its 52-week high with a 7.4% 5-day and 17% 30-day gain — strong, sustained defensive momentum.
Average probability across the 3 agent(s) that selected it was 69% raw (59% after calibration), below the 62% minimum to qualify.
- CTASCintas CorporationDropped at merge
Scout: 3% off its 52-week high with steady double-digit 30-day gains; low-beta uniform/services leader benefiting from rotation.
Average probability across the 2 agent(s) that selected it was 76% raw (59% after calibration), below the 62% minimum to qualify.
- COSTCostco Wholesale CorporationDropped at merge
Scout: Near its highs (-2.8%) with consistent 7%/14% 5-/30-day gains; defensive retail momentum intact.
Average probability across the 2 agent(s) that selected it was 60% raw (59% after calibration), below the 62% minimum to qualify.
- CCEPCoca-Cola Europacific Partners PLCDropped at merge
Scout: Within 1.5% of its 52-week high with a strong 15% 30-day advance, reflecting beverage-sector rotation strength.
Average probability across the 3 agent(s) that selected it was 69% raw (59% after calibration), below the 62% minimum to qualify.
- KDPKeurig Dr Pepper Inc.Already held
Scout: Within 2.6% of its 52-week high on an 18.5% 30-day move, suggesting a durable re-rating rather than a one-day spike.
Already held: a position opened 2026-11-04 runs until 2026-12-04 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
- MDLZMondelez International, Inc.Dropped at merge
Scout: Just 2.8% from its 52-week high with steady 7%/12% 5-/30-day gains; consumer-staples momentum play.
Average probability across the 4 agent(s) that selected it was 68% raw (59% after calibration), below the 62% minimum to qualify.
- ROPRoper Technologies, Inc.Passed over
Scout: Only 3.2% from its high with a 35% 30-day surge and continued 9% 5-day gain — one of the strongest momentum profiles in the index.
Aria: RSI near 82 after a +35% run in 30 days looks extremely overbought and due for a pullback, despite otherwise bullish signals.
Blaze: Despite a genuine guidance raise, the stock has already surged 35% in 30 days and RSI near 82 signals extreme overbought conditions — too extended to chase for another 5% without a pullback first
Nova: Up 35% in a month with an RSI near 82 — dangerously overbought with no confirmed catalyst behind the move
Orion: RSI near 82 signals an extremely stretched rally; the odds of a near-term pullback outweigh the sector tailwind for a brand-new position
Quinn: RSI above 78 signals the breakout may already be overextended, reducing probability versus other candidates
- MARMarriott International, Inc.Dropped at merge
Scout: 3.7% from its 52-week high with a 15.5% 30-day gain; travel/hospitality showing resilient demand.
Average probability across the 3 agent(s) that selected it was 64% raw (59% after calibration), below the 62% minimum to qualify.
- MNSTMonster Beverage CorporationDropped at merge
Scout: 4.7% off its high with a consistent 3%/11% 5-/30-day gain, benefiting from the defensive-staples rotation.
Only Quinn selected this stock — Quinn solo picks require High or Very High confidence and at least 60% probability (this pick: Medium, 60% raw (59% after calibration)).
- XELXcel Energy Inc.Already held
Scout: 4.6% from its 52-week high with a steady 10.5% 30-day gain; utilities attracting safety-seeking flows.
Already held: a position opened 2026-11-03 runs until 2026-12-03 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
- SBUXStarbucks CorporationDropped at merge
Scout: Near its highs (-4.8%) with a 10.5% 30-day gain, indicating a turnaround narrative gaining traction.
Average probability across the 2 agent(s) that selected it was 65% raw (59% after calibration), below the 62% minimum to qualify.
- AMGNAmgen Inc.Already held
Scout: Only 4.9% below its 52-week high with a 14.3% 30-day gain; biotech/healthcare defensive momentum.
Already held: a position opened 2026-10-29 runs until 2026-11-28 (23 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
- LINLinde plcPassed over
Scout: 4.9% from its high with steady 3.6%/6.4% 5-/30-day gains; industrial-gas defensive compounder near highs.
Aria: A volume-divergence warning plus the 50-day average still sitting below the 200-day average suggest the longer-term trend hasn't caught up to the recent bounce.
Nova: Last earnings beat was only 1.6% — too small to count as a meaningful catalyst
Orion: Weakest momentum of the favored-sector group, with the smallest performance gap versus the broader market
- MSFTMicrosoft CorporationPassed over
Scout: Only 4.2% from its 52-week high and still positive on both windows while AI-infra peers collapse — relative strength stands out.
Aria: 5-day momentum turned negative (-0.3%), failing the short-term trend requirement despite longer-term strength.
Blaze: Beat earnings by a wide margin but the stock has barely moved in 30 days with a bearish momentum signal, suggesting the good news is already priced in
Nova: 5-day price momentum is slightly negative, so there's no fresh positive move to support a short-term gain thesis
Orion: Mega-cap tech/growth names are out of favor in the current defensive rotation, despite being a high-quality business
Quinn: None of the momentum conditions (oversold RSI, positive MACD histogram, Bollinger squeeze, or golden cross) are currently met, so no setup qualifies
- AAPLApple Inc.Passed over
Scout: Just 3.2% off its 52-week high with a 3.2% 30-day gain, showing resilience versus the broader tech/semi drawdown.
Aria: 5-day momentum turned negative (-1.3%), so it fails the momentum screen even though the 30-day trend is positive.
Blaze: Beat earnings but 5-day price momentum has turned slightly negative and heavy insider selling, including by the CEO, is a yellow flag
Nova: 5-day price momentum is negative and technical indicators show a bearish MACD crossover
Quinn: MACD histogram is negative and 5-day momentum is slightly negative, weakening the bullish case despite a Bollinger squeeze
- GILDGilead Sciences, Inc.Already held
Scout: 5.1% from its 52-week high with a steady 16% 30-day gain; biopharma showing durable strength.
Already held: a position opened 2026-10-30 runs until 2026-11-29 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
- WMTWalmart Inc.Already held
Scout: 5.5% off its high with a 19% 30-day gain; large-cap retail benefiting from defensive positioning.
Already held: a position opened 2026-11-02 runs until 2026-12-02 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
- PAYXPaychex, Inc.Dropped at merge
Scout: 6.6% from its high with a 9.3%/18.3% 5-/30-day gain; payroll-services momentum mirrors ADP's strength.
Average probability across the 3 agent(s) that selected it was 73% raw (59% after calibration), below the 62% minimum to qualify.
- GEHCGE HealthCare Technologies Inc.Dropped at merge
Scout: 6.7% from its 52-week high with a 29.3% 30-day surge and 9.6% 5-day gain — strong healthcare momentum.
Average probability across the 2 agent(s) that selected it was 72% raw (59% after calibration), below the 62% minimum to qualify.
- EXCExelon CorporationDropped at merge
Scout: 8.1% from its high with an 11.6% 30-day gain; regulated utility benefiting from the flight to safety.
Average probability across the 4 agent(s) that selected it was 66% raw (59% after calibration), below the 62% minimum to qualify.
- KHCThe Kraft Heinz CompanyDropped at merge
Scout: 9.9% from its high but with a sustained 5.9%/14.9% 5-/30-day gain, riding the staples rotation.
Average probability across the 2 agent(s) that selected it was 70% raw (59% after calibration), below the 62% minimum to qualify.
- AMZNAmazon.com, Inc.Already held
Scout: 6.7% 5-day gain and only 9.4% from its 52-week high, showing a recent bounce with room to retest highs.
Already held: a position opened 2026-11-04 runs until 2026-12-04 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
- REGNRegeneron Pharmaceuticals, Inc.Dropped at merge
Scout: 10.3%/22.2% 5-/30-day gains and only 9% from its 52-week high; biotech momentum remains strong.
Average probability across the 3 agent(s) that selected it was 66% raw (59% after calibration), below the 62% minimum to qualify.
- DXCMDexCom, Inc.Already held
Scout: 5.7% 5-day gain with only an 8.8% gap to its 52-week high; medtech showing a fresh momentum pickup.
Already held: a position opened 2026-11-04 runs until 2026-12-04 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
- IDXXIDEXX Laboratories, Inc.Dropped at merge
Scout: 16.5%/30.1% 5-/30-day gains, among the strongest in the index, with only a 12.9% gap to its 52-week high.
Average probability across the 2 agent(s) that selected it was 68% raw (59% after calibration), below the 62% minimum to qualify.